Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y
Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039
PMC: 11873319.
DOI: 10.1038/s41392-024-02081-y.
He B, Wilson B, Chen S, Sharma K, Scappini E, Cook M
Int J Mol Sci. 2024; 25(20).
PMID: 39456875
PMC: 11508178.
DOI: 10.3390/ijms252011094.
Cai A, Gao K, Zhang F, Jiang Y
World J Pediatr. 2024; 20(11):1115-1137.
PMID: 39395088
DOI: 10.1007/s12519-024-00843-w.
Yamada W, Tomoshige S, Nakamura S, Sato S, Ishikawa M
Chem Sci. 2024; .
PMID: 39246353
PMC: 11376192.
DOI: 10.1039/d4sc03145h.
Lau C, Liang Q, Zhu H
Transgenic Res. 2024; 33(5):323-357.
PMID: 39158822
DOI: 10.1007/s11248-024-00404-x.
Targeting Mitochondrial Complex I Deficiency in MPP/MPTP-induced Parkinson's Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene.
Li H, Zhang J, Shen Y, Ye Y, Jiang Q, Chen L
Biol Proced Online. 2024; 26(1):9.
PMID: 38594619
PMC: 11003148.
DOI: 10.1186/s12575-024-00236-3.
FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease.
Kodavati M, Wang H, Guo W, Mitra J, Hegde P, Provasek V
Nat Commun. 2024; 15(1):2156.
PMID: 38461154
PMC: 10925063.
DOI: 10.1038/s41467-024-45978-6.
Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber's Hereditary Optic Neuropathy.
Chou T, Hao Z, Alba D, Lazo A, Gallo Afflitto G, Eastwood J
Int J Mol Sci. 2023; 24(23).
PMID: 38069388
PMC: 10707051.
DOI: 10.3390/ijms242317068.
Second-Generation Polyamidoamine Dendrimer Conjugated with Oligopeptides Can Enhance Plasmid DNA Delivery In Vitro.
Kim S, Thuy L, Lee J, Choi J
Molecules. 2023; 28(22).
PMID: 38005366
PMC: 10674462.
DOI: 10.3390/molecules28227644.
Clinical Approaches for Mitochondrial Diseases.
Hong S, Kim S, Kim K, Lee H
Cells. 2023; 12(20).
PMID: 37887337
PMC: 10605124.
DOI: 10.3390/cells12202494.
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy.
Shamsnajafabadi H, MacLaren R, Cehajic-Kapetanovic J
Cells. 2023; 12(15).
PMID: 37566092
PMC: 10416882.
DOI: 10.3390/cells12152013.
Functionalized and Nonfunctionalized Nanosystems for Mitochondrial Drug Delivery with Metallic Nanoparticles.
Misra S, Rosenholm J, Pathak K
Molecules. 2023; 28(12).
PMID: 37375256
PMC: 10301343.
DOI: 10.3390/molecules28124701.
Trends and prospects in mitochondrial genome editing.
Phan H, Lee H, Kim K
Exp Mol Med. 2023; 55(5):871-878.
PMID: 37121968
PMC: 10238537.
DOI: 10.1038/s12276-023-00973-7.
Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model.
Velmurugan S, Chou T, Eastwood J, Porciatti V, Liu Y, Hauswirth W
Front Neurosci. 2023; 17:1119724.
PMID: 37051151
PMC: 10083341.
DOI: 10.3389/fnins.2023.1119724.
Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks.
McGrady N, Boal A, Risner M, Taiel M, Sahel J, Calkins D
Mol Ther. 2023; 31(7):2005-2013.
PMID: 37016579
PMC: 10362393.
DOI: 10.1016/j.ymthe.2023.03.035.
Current Advances in Gene Therapies of Genetic Auditory Neuropathy Spectrum Disorder.
Saidia A, Ruel J, Bahloul A, Chaix B, Venail F, Wang J
J Clin Med. 2023; 12(3).
PMID: 36769387
PMC: 9918155.
DOI: 10.3390/jcm12030738.
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches.
Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J
Pharmaceutics. 2022; 14(12).
PMID: 36559149
PMC: 9785072.
DOI: 10.3390/pharmaceutics14122657.
Current advances in gene therapy of mitochondrial diseases.
Soldatov V, Kubekina M, Skorkina M, Belykh A, Egorova T, Korokin M
J Transl Med. 2022; 20(1):562.
PMID: 36471396
PMC: 9724384.
DOI: 10.1186/s12967-022-03685-0.
Developments in the Treatment of Leber Hereditary Optic Neuropathy.
Chen B, Yu-Wai-Man P, Newman N
Curr Neurol Neurosci Rep. 2022; 22(12):881-892.
PMID: 36414808
PMC: 9750907.
DOI: 10.1007/s11910-022-01246-y.
cNap1 bridges centriole contact sites to maintain centrosome cohesion.
Mahen R
PLoS Biol. 2022; 20(10):e3001854.
PMID: 36282799
PMC: 9595518.
DOI: 10.1371/journal.pbio.3001854.